by Phil Calvin | November 30, 2020
Phil Calvin, Vineti’s Chief Technology Officer, is a long-time leader in enterprise software, with more than 25 years of entrepreneurial and executive experience, including nearly a decade at Salesforce.
by Joe DePinto | November 23, 2020
Joe DePinto, Vineti’s Chief Commercial Officer, is a long-time leader in cell and gene therapies, and a veteran biotech and pharma executive with more than 28 years of experience.
by Louise Pacini and Amy Fonte | November 17, 2020
Patient-specific therapeutics must be delivered to the patient they are intended to treat. That concept is easy to say -- and not always easy to do. An entire ecosystem of workflows, drug product processes, and supply chain steps must be orchestrated…
by Amy DuRoss | November 17, 2020
A Vineti technology perspective from CEO and Co-founder Amy DuRoss
by Amy DuRoss | October 13, 2020
Vineti, Inc., the leading digital platform of record for personalized therapeutics, today announced the closing of a $33 million extension to its Series C financing. The new financing will support further expansion of the company’s Personalized…